EKF Diagnostics acquires Selah Genomics and DiaSpect Medical AB

24-Apr-2014 - United Kingdom

EKF Diagnostics announces that it has acquired Selah Genomics, Inc. and DiaSpect Medical AB. Sweden based DiaSpect manufactures desktop hemoglobin analyzers, whilst Selah, of South Carolina is a service provider that supplies molecular diagnostics tests for the development of personalized medicine.

Other news from the department business & finance

Most read news

More news from our other portals

Under the magnifying glass: The world of microscopy